The use of biosynthetic human growth hormone to augment ovulation induction with buserelin acetate/human menopausal gonadotropin in women with a poor ovarian response.
The present study has demonstrated the usefulness of GH in augmenting buserelin acetate/hMG to stimulate the rate of growth of follicles in women regarded as poor responders. The PR achieved was extremely encouraging in a group of patients whose prognosis was otherwise poor. Further studies are required to confirm these preliminary data.
Ibrahim
Z H
ZH
Regional IVF Unit, Saint Mary's Hospital, Manchester, United Kingdom.
Matson
P L
PL
Buck
P
P
Lieberman
B A
BA
D000328:Adult; D002064:Buserelin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005307:Fertilization in Vitro; D015181:Gamete Intrafallopian Transfer; D013006:Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D008596:Menotropins / Q000627:therapeutic use*; D010062:Ovulation Induction
D008596:Menotropins; D013006:Growth Hormone; D002064:Buserelin